NICE and drugs for multiple sclerosis. National Institute of Clinical Excellence
- PMID: 11009171
- DOI: 10.1016/s0140-6736(05)74558-x
NICE and drugs for multiple sclerosis. National Institute of Clinical Excellence
Comment on
-
Randomised double-blind placebo-controlled study of interferon beta-1a in relapsing/remitting multiple sclerosis. PRISMS (Prevention of Relapses and Disability by Interferon beta-1a Subcutaneously in Multiple Sclerosis) Study Group.Lancet. 1998 Nov 7;352(9139):1498-504. Lancet. 1998. PMID: 9820297 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
